In response to evolving healthcare needs and industry trends, the demand for unit-dose-delivery devices and packaging is projecting to experience a significant spike in the coming years. According to a recent analysis by the Freedonia Group titled “The Global Unit Dose Pharmaceutical Packaging Report,” this demand is expecting to grow at an annual rate of 6.4%, reaching nearly $57.9 billion by 2025.
Driving Factors
Blister packaging for solid dose applications is anticipating to lead the global market; prefillable syringes experiencing the fastest growth. The push for improved patient compliance through packaging designs is a key trend fueling the demand for unit-dose packaging. This includes the widespread adoption of blister and strip packs, as well as other unit-dose containers, to enhance medication adherence and record-keeping.
Competition and Innovation
Intensifying generic and private label competition within the pharmaceutical industry is driving the upgrade of packaging containers. The goal is to influence consumer and medical provider buying decisions. This trend particularly benefits unit-dose blister packs, which are favored for their convenience and aesthetic appeal. Bill Martineau, a Freedonia analyst, notes that efforts to enhance pharmaceutical packaging properties are more pronounced in over-the-counter medications and supplements, focusing on retail store sales. On the other hand, ethical pharmacy packaging concentrates on infection prevention and ease-of-delivery features.
Responding to Emerging Needs
The exposure of new therapies and vaccines for various diseases, including cancer and viral disorders, is expecting to propel demand for unit-dose prefillable syringes. These medications are typically packaged in unit-dose containers due to their precise dosage requirements and the need for easy administration. Additionally, the ongoing enhancements in syringe design and safety have led to a rise in self-injection therapies. This will further boost the demand for unit-dose prefillable syringes and parenteral vials.
Infection Prevention and Preventive Medicine
With a heightened focus on infection prevention in healthcare settings, unit-dose syringes are becoming increasingly popular for use; primarily in hospitals, clinics, physicians’ offices, and nursing homes. Moreover, the growth of global preventive medicine, particularly in response to diseases like COVID-19, influenza, meningitis, and shingles, necessitates single-dose injectable vaccines, further driving demand for unit-dose formats.
Conclusion
As the demand for unit-dose pharmaceutical packaging continues to surge, companies like Atlantic Biologicals are eager to play a crucial role in meeting these evolving needs. Atlantic Biologicals commits to staying at the forefront of innovation and collaboration within healthcare. The company provides high-quality unit-dose packaging solutions to enhance patient safety, medication adherence, and overall healthcare outcomes.
